Evidence map›Paper›PMID 24392086›Full record

Trial reportPloS one2014

Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study.

Charlotte Salter, Lisa McDaid, Debi Bhattacharya, Richard Holland, Tarnya Marshall, Amanda Howe

Open access · goldAbstract readClinical TrialMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 7 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 7 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Communication Processes Related to Decision-Making in Medication Management Between Healthcare Providers, Older People and Their Carers: A Systematic Review.Health expectations : an international journal of public participation in health care and health policy · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Pooled it
  5. A systematic review of factors affecting medication adherence among patients with osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Trial
  10. Systematic screening using FRAXOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Trial
  11. Article
  12. Article
  13. Review
  14. Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Review
  15. Patients experience a need for informal care after a fragility fracture.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Charlotte SalterNorwich Medical School, Faculty of Medicine & Health Science, University of East Anglia, Norwich, Norfolk, United Kingdom.
Lisa McDaidNorwich Medical School, Faculty of Medicine & Health Science, University of East Anglia, Norwich, Norfolk, United Kingdom.
Debi BhattacharyaSchool of Chemistry and Pharmacy, University of East Anglia, Norwich, Norfolk. United Kingdom.
Richard HollandNorwich Medical School, Faculty of Medicine & Health Science, University of East Anglia, Norwich, Norfolk, United Kingdom.
Tarnya MarshallRheumatology Department, Norfolk & Norwich University Foundation Trust Hospital. Norwich, Norfolk. United Kingdom.
Amanda HoweNorwich Medical School, Faculty of Medicine & Health Science, University of East Anglia, Norwich, Norfolk, United Kingdom.
University of East Anglia · GB

Funding

Department of Health PB-PG-0807-14068
6 · The paper itself

Abstract

backgroundThere is significant morbidity and mortality caused by the complications of osteoporosis, for which ageing is the greatest epidemiological risk factor. Preventive medications to delay osteoporosis are available, but little is known about motivators to adhere to these in the context of a symptomless condition with evidence based on screening results.

aimTo describe key perceptions that influence older women's adherence and persistence with prescribed medication when identified to be at a higher than average risk of fracture. DESIGN OF STUDY: A longitudinal qualitative study embedded within a multi-centre trial exploring the effectiveness of screening for prevention of fractures.

settingPrimary care, Norfolk. United Kingdom.

methodsThirty older women aged 70-85 years of age who were offered preventive medication for osteoporosis and agreed to undertake two interviews at 6 and 24 months post-first prescription.

resultsThere were no overall predictors of adherence which varied markedly over time. Participants' perceptions and motivations to persist with medication were influenced by six core themes: understanding adherence and non-adherence, motivations and self-care, appraising and prioritising risk, anticipating and managing side effects, problems of understanding, and decision making around medication. Those engaged with supportive professionals could better tolerate and overcome barriers such as side-effects.

conclusionsMany issues are raised following screening in a cohort of women who have not previously sought advice about their bone health. Adherence to preventive medication for osteoporosis is complex and multifaceted. Individual participant understanding, choice, risk and perceived need all interact to produce unpredictable patterns of usage and acceptability. There are clear implications for practice and health professionals should not assume adherence in any older women prescribed medication for the prevention of osteoporosis. The beliefs and motivations of participants and their healthcare providers regarding the need to establish acceptable medication regimes is key to promoting and sustaining adherence.

Indexed as

ChemopreventionMedication AdherenceAgedAged, 80 and overAge FactorsBone Density Conservation AgentsDecision MakingDiphosphonatesFemaleHumansLongitudinal StudiesOsteoporosis, PostmenopausalPrimary Health CareQualitative ResearchUnited KingdomBone Density Conservation AgentsDiphosphonates

Identifiers

PMID24392086
PMCPMC3879247
OpenAlexW2028457344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.